LncRNA BRCAT54 is downregulated and inhibits cancer cell proliferation by downregulating miR‐130b‐3p through methylation in prostate cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LncRNA BRCAT54 is downregulated and inhibits cancer cell proliferation by downregulating miR‐130b‐3p through methylation in prostate cancer
Authors
Keywords
-
Journal
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-27
DOI
10.1002/jbt.23552
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long non-coding RNA BRCAT54 sponges microRNA-21 in vestibular schwannoma to suppress cell proliferation
- (2022) Gang Xiao et al. Bioengineered
- Exosomal miR-130b-3p Promotes Progression and Tubular Formation Through Targeting PTEN in Oral Squamous Cell Carcinoma
- (2021) Wei Yan et al. Frontiers in Cell and Developmental Biology
- LncRNA BRCAT54 inhibits the tumorigenesis of non-small cell lung cancer by binding to RPS9 to transcriptionally regulate JAK-STAT and calcium pathway genes
- (2020) Wenhan Yang et al. CARCINOGENESIS
- Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer
- (2020) Cora N. Sternberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prostate Cancer Brain Metastases: A Single-Institution Experience
- (2020) Hriday P. Bhambhvani et al. World Neurosurgery
- Exosomal miR-130b-3p targets SIK1 to inhibit medulloblastoma tumorigenesis
- (2020) Saihua Huang et al. Cell Death & Disease
- Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
- (2020) Maha Hussain et al. NEW ENGLAND JOURNAL OF MEDICINE
- LncRNAs in cancer: Regulatory and therapeutic implications
- (2020) Arun Nandwani et al. CANCER LETTERS
- Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis
- (2019) Sarah Burdett et al. EUROPEAN UROLOGY
- Prostate Cancer and Bone Metastases: The Underlying Mechanisms
- (2019) Sok Kuan Wong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Global incidence of prostate cancer in developing and developed countries with changing age structures
- (2019) Jeremy Y. C. Teoh et al. PLoS One
- Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol
- (2018) M R Sydes et al. ANNALS OF ONCOLOGY
- Clinical implications of PTEN loss in prostate cancer
- (2018) Tamara Jamaspishvili et al. Nature Reviews Urology
- The Epidemiology of Prostate Cancer
- (2018) Claire H. Pernar et al. Cold Spring Harbor Perspectives in Medicine
- Managing Nonmetastatic Castration-resistant Prostate Cancer
- (2018) Joaquin Mateo et al. EUROPEAN UROLOGY
- Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer
- (2018) Chengfei Liu et al. Nature Communications
- Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study
- (2017) Marco Bandini et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Roles for MicroRNAs, miR-93 and miR-130b, and Tumor Protein 53–Induced Nuclear Protein 1 Tumor Suppressor in Cell Growth Dysregulation by Human T-Cell Lymphotrophic Virus 1
- (2008) Man Lung Yeung et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search